Aspire expands oncology portfolio with prostate cancer hormone therapy
One man dies from prostate cancer every 45 minutes in the UKÂ
Aspire Pharma Limited has solidified its position as a leading specialty generics enterprise...
Aspire Pharma completes acquisition of Cenoté Pharma
The specialty generics business is also looking to gain regulatory approval in multiple global markets
Aspire Pharma Limited, a leading UK provider of niche generic...
 Aspire Pharma acquires Morningside Pharmaceuticals and its subsidiaries
Morningside Pharmaceuticals, a leading pharmaceutical group founded by an Asian businessman and his wife, has been acquired by Hampshire-based Aspire Pharma.
Morningside Pharmaceuticals (Loughborough), Morningside...